Pubrio sells to AI agents - live prices and self-serve payment

The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.

pubrio
Daiichi Sankyo Europe GmbH logo

Daiichi Sankyo Europe GmbH

Self-Owned
제약 제조1,300+ employeesFounded 1899🇩🇪 독일
본사
🇩🇪Munich (+1)
산업
제약 제조
직원
1,300+
설립
1899
회사 유형
Self-Owned
순위
#4,168,032

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/imprint/ All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

전문 분야
제약생명 공학의료제약 제조
12 / 14
활성 시장
터키 · 이탈리아 · 스위스
0
신규 시장
이번 기간 없음
22
시그널
최근 90일
-62%
모멘텀
이전 기간 대비
확장 점수성장 중
28 / 100

글로벌 확장

실시간
터키이탈리아스위스
최대 3개 시장
최근 90일
단계
탐색 중5투입 중9확장 중0규모 확대 중0
최근 활동
진행 중30일
신규90일
+11개 시장 더잠김
14개 중 3개 표시

시장 타임라인 및 시그널 피드 잠금 해제

활동 펄스

최근 90일간 시그널 22건.

최근 90일
채용
12
채용
마케팅 및 PR
9↓ 종료
광고
제품 및 기술
1↓ 종료
클라우드 확장
+2개 카테고리 더잠김
5개 중 3개 표시

시장 진입 타임라인

이 회사가 각 시장에 진입한 순서 — 오래된 순부터 최신 순까지

1
🇹🇷터키1st 진입 시장 · 2024
투입 중
시그널 29건
2
🇨🇭스위스2nd 진입 시장 · 2024
투입 중
시그널 27건
3
🇮🇹이탈리아3rd 진입 시장 · 2025
탐색 중
시그널 28건
+11개 시장 더잠김
14개 중 3개 표시
현재 단계투입 중자원 투입 중
신뢰도39%낮음
추적 시작2024첫 시그널

최근 시그널

채용🇮🇪 아일랜드오늘

Brand Manager Oncology

채용🇵🇹 포르투갈지난주

PT-Marketing Manager Oncology

가입하고 전체 시그널 피드를 확인하세요

알아두면 좋은 정보

Daiichi Sankyo Europe GmbH 관련 자주 묻는 질문

Daiichi Sankyo Europe GmbH의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field. We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company. In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. Imprint: https://www.daiichi-sankyo.eu/imprint/ All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

800M+
모니터링 기업
50+
로컬 데이터 소스
16
움직임 시그널
매일
갱신 주기
“기업이 시장에 진입한 그 주에 고객을 만납니다 — 다음 분기가 아니라.”
그로스 총괄 · Pubrio를 쓰는 500명 이상 규모의 매출 팀

전 세계 기업의 움직임을 포착하세요.

무브먼트 맵 둘러보기를 저희 팀과 함께 예약하세요.

pubrio

Pubrio는 200개 이상의 시장에 걸친 확장 시그널을 하나의 라이브 그래프로 묶어, 어떤 기업이 새로운 시장에 진입하는지 매출 팀에 보여주고 타이밍을 잡게 합니다.

팔로우

AI에게 Pubrio에 대해 물어보기

AI 에이전트용

Pubrio - Agent Storefront, powered by ZeroClick

© 2026 Pubrio. 모든 권리 보유.